These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 18583113)
21. Effects of Buffer Composition on Site-Specific Glycation of Lysine Residues in Monoclonal Antibodies. Jacobitz AW; Dykstra AB; Spahr C; Agrawal NJ J Pharm Sci; 2020 Jan; 109(1):293-300. PubMed ID: 31150698 [TBL] [Abstract][Full Text] [Related]
22. Freeze drying of human serum albumin (HSA) nanoparticles with different excipients. Anhorn MG; Mahler HC; Langer K Int J Pharm; 2008 Nov; 363(1-2):162-9. PubMed ID: 18672043 [TBL] [Abstract][Full Text] [Related]
23. Investigation of N-terminal glutamate cyclization of recombinant monoclonal antibody in formulation development. Yu L; Vizel A; Huff MB; Young M; Remmele RL; He B J Pharm Biomed Anal; 2006 Oct; 42(4):455-63. PubMed ID: 16828250 [TBL] [Abstract][Full Text] [Related]
24. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations. Garidel P; Pevestorf B; Bahrenburg S Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339 [TBL] [Abstract][Full Text] [Related]
25. Stability of lyophilized sucrose formulations of an IgG1: subvisible particle formation. Davis JM; Zhang N; Payne RW; Murphy BM; Abdul-Fattah AM; Matsuura JE; Herman AC; Manning MC Pharm Dev Technol; 2013; 18(4):883-96. PubMed ID: 22813478 [TBL] [Abstract][Full Text] [Related]
26. Conformational studies of a monoclonal antibody, IgG1, by chemical oxidation: structural analysis by ultrahigh-pressure LC-electrospray ionization time-of-flight MS and multivariate data analysis. Zamani L; Andersson FO; Edebrink P; Yang Y; Jacobsson SP Anal Biochem; 2008 Sep; 380(2):155-63. PubMed ID: 18577369 [TBL] [Abstract][Full Text] [Related]
27. Comparative LC-MS/MS profiling of free and protein-bound early and advanced glycation-induced lysine modifications in dairy products. Hegele J; Buetler T; Delatour T Anal Chim Acta; 2008 Jun; 617(1-2):85-96. PubMed ID: 18486644 [TBL] [Abstract][Full Text] [Related]
29. Unveiling a glycation hot spot in a recombinant humanized monoclonal antibody. Zhang B; Yang Y; Yuk I; Pai R; McKay P; Eigenbrot C; Dennis M; Katta V; Francissen KC Anal Chem; 2008 Apr; 80(7):2379-90. PubMed ID: 18307322 [TBL] [Abstract][Full Text] [Related]
30. A critical evaluation of Tm(FTIR) measurements of high-concentration IgG1 antibody formulations as a formulation development tool. Matheus S; Mahler HC; Friess W Pharm Res; 2006 Jul; 23(7):1617-27. PubMed ID: 16783474 [TBL] [Abstract][Full Text] [Related]
31. Formulation development and manufacturing of a gastrin/CCK-2 receptor targeting peptide as an intermediate drug product for a clinical imaging study. Sosabowski JK; Lee M; Dekker BA; Simmons BP; Singh S; Beresford H; Hagan SA; McKenzie AJ; Mather SJ; Watson SA Eur J Pharm Sci; 2007 Jun; 31(2):102-11. PubMed ID: 17387005 [TBL] [Abstract][Full Text] [Related]
32. Stability of low concentrations of guanine-based antivirals in sucrose or maltitol solutions. Desai D; Rao V; Guo H; Li D; Bolgar M Int J Pharm; 2007 Sep; 342(1-2):87-94. PubMed ID: 17583451 [TBL] [Abstract][Full Text] [Related]
33. Glycation of lysine-containing dipeptides. Mennella C; Visciano M; Napolitano A; Del Castillo MD; Fogliano V J Pept Sci; 2006 Apr; 12(4):291-6. PubMed ID: 16180244 [TBL] [Abstract][Full Text] [Related]
34. Capillary electrophoretic analysis of advanced glycation endproducts formed from the reaction of reducing sugars with the amino group of glucosamine. Dutta U; Dain JA Anal Biochem; 2005 Aug; 343(2):237-43. PubMed ID: 15992760 [TBL] [Abstract][Full Text] [Related]
35. Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method. Jocić B; Zecević M; Zivanović L; Protić A; Jadranin M; Vajs V J Pharm Biomed Anal; 2009 Nov; 50(4):622-9. PubMed ID: 19250786 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of microwave oven heating for prediction of drug-excipient compatibilities and accelerated stability studies. Schou-Pedersen AM; Østergaard J; Cornett C; Hansen SH Int J Pharm; 2015 May; 485(1-2):97-107. PubMed ID: 25746946 [TBL] [Abstract][Full Text] [Related]
37. Evaluating the extent of protein damage in dairy products: simultaneous determination of early and advanced glycation-induced lysine modifications. Hegele J; Parisod V; Richoz J; Förster A; Maurer S; Krause R; Henle T; Bütler T; Delatour T Ann N Y Acad Sci; 2008 Apr; 1126():300-6. PubMed ID: 18448835 [TBL] [Abstract][Full Text] [Related]
38. Glycation of a lysine-containing tetrapeptide by D-glucose and D-fructose--influence of different reaction conditions on the formation of Amadori/Heyns products. Jakas A; Katić A; Bionda N; Horvat S Carbohydr Res; 2008 Sep; 343(14):2475-80. PubMed ID: 18656854 [TBL] [Abstract][Full Text] [Related]
39. Recent trends in stabilising peptides and proteins in pharmaceutical formulation - considerations in the choice of excipients. Jorgensen L; Hostrup S; Moeller EH; Grohganz H Expert Opin Drug Deliv; 2009 Nov; 6(11):1219-30. PubMed ID: 19678792 [TBL] [Abstract][Full Text] [Related]
40. Comparison of imaged capillary isoelectric focusing and cation exchange chromatography for monitoring dextrose-mediated glycation of monoclonal antibodies in infusion solutions. Demirdirek B; Lan W; Qiu D; Ding W; Iyer LK; Bolgar MS; Valente JJ J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():156-163. PubMed ID: 30594826 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]